Table of Content

Table of Contents

Global Immune Cell Therapy Drugs Market Segment Research Report 2022
1. Research Scope
2. Market Overview
2.1 Product Introduction, Application, Picture
2.2 Global Immune Cell Therapy Drugs Market by Value
2.2.1 Global Immune Cell Therapy Drugs Revenue by Type
2.2.2 Global Immune Cell Therapy Drugs Market by Value (%)
2.3 Global Immune Cell Therapy Drugs Market by Production
2.3.1 Global Immune Cell Therapy Drugs Production by Type
2.3.2 Global Immune Cell Therapy Drugs Market by Production (%)

3. The Major Driver of Immune Cell Therapy Drugs Industry
3.1 Historical & Forecast Global Immune Cell Therapy Drugs Demand
3.2 Largest Application for Immune Cell Therapy Drugs (2018-2028)
3.3 The Major Downstream Company in China Market 2022

4. Global and Regional Immune Cell Therapy Drugs Market
4.1 Regional Market Size in Terms of Production & Demand (2022)
4.2 Regional Market Share in Terms of Revenue (2018-2022)
4.3 Concentration Ratio (CR5& CR10) of Immune Cell Therapy Drugs Market
4.4 Mergers & Acquisitions, Expansion Plans

5. US Immune Cell Therapy Drugs Production, Revenue (2018-2028)
5.1 Current and Estimated Production Breakdown by Type
5.2 Current and Estimated Production Breakdown by Application
5.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
5.4 Current and Estimated Revenue Breakdown by Application (2018-2028)

6. Europe Immune Cell Therapy Drugs Production, Revenue (2018-2028)
6.1 Current and Estimated Production Breakdown by Type
6.2 Current and Estimated Production Breakdown by Application
6.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
6.4 Current and Estimated Revenue Breakdown by Application (2018-2028)

7. China Immune Cell Therapy Drugs Production, Revenue (2018-2028)
7.1 Current and Estimated Production Breakdown by Type
7.2 Current and Estimated Production Breakdown by Application
7.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
7.4 Current and Estimated Revenue Breakdown by Application (2018-2028)

8. Japan Immune Cell Therapy Drugs Production, Revenue (2018-2028)
8.1 Current and Estimated Production Breakdown by Type
8.2 Current and Estimated Production Breakdown by Application
8.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
8.4 Current and Estimated Revenue Breakdown by Application (2018-2028)

9. India Immune Cell Therapy Drugs Production, Revenue (2018-2028)
9.1 Current and Estimated Production Breakdown by Type
9.2 Current and Estimated Production Breakdown by Application
9.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
9.4 Current and Estimated Revenue Breakdown by Application (2018-2028)

10. Korea Immune Cell Therapy Drugs Production, Revenue (2018-2028)
10.1 Current and Estimated Production Breakdown by Type
10.2 Current and Estimated Production Breakdown by Application
10.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
10.4 Current and Estimated Revenue Breakdown by Application (2018-2028)

11. Southeast Asia Immune Cell Therapy Drugs Production, Revenue (2018-2028)
11.1 Current and Estimated Production Breakdown by Type
11.2 Current and Estimated Production Breakdown by Application
11.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
11.4 Current and Estimated Revenue Breakdown by Application (2018-2028)

12. Global Immune Cell Therapy Drugs Average Price Trend
12.1 Market Price for Each Type of Immune Cell Therapy Drugs in US (2018-2022)
12.2 Market Price for Each Type of Immune Cell Therapy Drugs in Europe (2018-2022)
12.3 Market Price for Each Type of Immune Cell Therapy Drugs in China (2018-2022)
12.4 Market Price for Each Type of Immune Cell Therapy Drugs in Japan (2018-2022)
12.5 Market Price for Each Type of Immune Cell Therapy Drugs in India (2018-2022)
12.6 Market Price for Each Type of Immune Cell Therapy Drugs in Korea (2018-2022)
12.7 Market Price for Each Type of Immune Cell Therapy Drugs in Southeast Asia (2018-2022)

13. Industrial Chain (Impact of COVID-19)
13.1 Immune Cell Therapy Drugs Industrial Chain Analysis
13.2 Downstream
13.3 Impact of COVID-19
13.4 Post-pandemic Era
13.5 Technology Trends of Immune Cell Therapy Drugs

14. Immune Cell Therapy Drugs Competitive Landscape
14.1 Aquila BioMedical
14.1.1 Aquila BioMedical Company Profiles
14.1.2 Aquila BioMedical Product Introduction
14.1.3 Aquila BioMedical Immune Cell Therapy Drugs Production, Revenue (2018-2022)
14.1.4 Strategic initiatives
14.2 BPS Bioscience
14.2.1 BPS Bioscience Company Profiles
14.2.2 BPS Bioscience Product Introduction
14.2.3 BPS Bioscience Immune Cell Therapy Drugs Production, Revenue (2018-2022)
14.2.4 Strategic initiatives
14.3 Celentyx
14.3.1 Celentyx Company Profiles
14.3.2 Celentyx Product Introduction
14.3.3 Celentyx Immune Cell Therapy Drugs Production, Revenue (2018-2022)
14.3.4 Strategic initiatives
14.4 Crown Bioscience
14.4.1 Crown Bioscience Company Profiles
14.4.2 Crown Bioscience Product Introduction
14.4.3 Crown Bioscience Immune Cell Therapy Drugs Production, Revenue (2018-2022)
14.4.4 Strategic initiatives
14.5 DiscoverX Corporation
14.5.1 DiscoverX Corporation Company Profiles
14.5.2 DiscoverX Corporation Product Introduction
14.5.3 DiscoverX Corporation Immune Cell Therapy Drugs Production, Revenue (2018-2022)
14.5.4 Strategic initiatives
14.6 Explicyte
14.6.1 Explicyte Company Profiles
14.6.2 Explicyte Product Introduction
14.6.3 Explicyte Immune Cell Therapy Drugs Production, Revenue (2018-2022)
14.6.4 Strategic initiatives
14.7 Genscript Biotech Corporation
14.7.1 Genscript Biotech Corporation Company Profiles
14.7.2 Genscript Biotech Corporation Product Introduction
14.7.3 Genscript Biotech Corporation Immune Cell Therapy Drugs Production, Revenue (2018-2022)
14.7.4 Strategic initiatives
14.8 HD Biosciences
14.8.1 HD Biosciences Company Profiles
14.8.2 HD Biosciences Product Introduction
14.8.3 HD Biosciences Immune Cell Therapy Drugs Production, Revenue (2018-2022)
14.8.4 Strategic initiatives
14.9 Horizon Discovery Group
14.9.1 Horizon Discovery Group Company Profiles
14.9.2 Horizon Discovery Group Product Introduction
14.9.3 Horizon Discovery Group Immune Cell Therapy Drugs Production, Revenue (2018-2022)
14.9.4 Strategic initiatives
14.10 ImmunXperts
14.10.1 ImmunXperts Company Profiles
14.10.2 ImmunXperts Product Introduction
14.10.3 ImmunXperts Immune Cell Therapy Drugs Production, Revenue (2018-2022)
14.10.4 Strategic initiatives
14.11 Molecular Imaging
14.12 Promega Corporation,Personalis
14.13 STC Biologics
15. Conclusion
16. Methodology and Data Source

List of Figure

List of Tables and Figures

Figure 1. Total Demand by Application of Immune Cell Therapy Drugs Industry (Volume)
Figure 2. Immune Cell Therapy Drugs Production & Demand by Regions in 2022
Figure 3. Regional Market Share in Terms of Revenue (2022&2027)
Figure 4. The Top 10 and 5 Players Market Share by Immune Cell Therapy Drugs Revenue in 2022
Figure 5. US Immune Cell Therapy Drugs Production, Demand (2018-2028)
Figure 6. Production Breakdown by Type (%)
Figure 7. Demand Breakdown by Type (%)
Figure 8. Demand Breakdown by Application (%)
Figure 9. Revenue Breakdown by Type (%)
Figure 10. Revenue Breakdown by Application (%)
Figure 11. Europe Immune Cell Therapy Drugs Production, Demand (2018-2028)
Figure 12. Production Breakdown by Type (%)
Figure 13. Demand Breakdown by Type (%)
Figure 14. Demand Breakdown by Application (%)
Figure 15. Revenue Breakdown by Type (%)
Figure 16. Revenue Breakdown by Application (%)
Figure 17. China Immune Cell Therapy Drugs Production, Demand (2018-2028)
Figure 18. Production Breakdown by Type (%)
Figure 19. Demand Breakdown by Type (%)
Figure 20. Demand Breakdown by Application (%)
Figure 21. Current and Estimated Revenue Breakdown by Type
Figure 22. Revenue Breakdown by Type (%)
Figure 23. Revenue Breakdown by Application (%)
Figure 24. Japan Immune Cell Therapy Drugs Production, Demand (2018-2028)
Figure 25. Production Breakdown by Type (%)
Figure 26. Demand Breakdown by Type (%)
Figure 27. Demand Breakdown by Application (%)
Figure 28. Revenue Breakdown by Type (%)
Figure 29. Revenue Breakdown by Application (%)
Figure 30. India Immune Cell Therapy Drugs Production, Demand (2018-2028)
Figure 31. Production Breakdown by Type (%)
Figure 32. Demand Breakdown by Type (%)
Figure 33. Demand Breakdown by Application (%)
Figure 34. Revenue Breakdown by Type (%)
Figure 35. Revenue Breakdown by Application (%)
Figure 36. Korea Immune Cell Therapy Drugs Production, Demand (2018-2028)
Figure 37. Production Breakdown by Type (%)
Figure 38. Demand Breakdown by Type (%)
Figure 39. Demand Breakdown by Application (%)
Figure 40. Revenue Breakdown by Type (%)
Figure 41. Revenue Breakdown by Application (%)
Figure 42. Southeast Asia Immune Cell Therapy Drugs Production, Demand (2018-2028)
Figure 43. Current and Estimated Production Breakdown by Type (2018-2028)
Figure 44. Production Breakdown by Type (%)
Figure 45. Demand Breakdown by Type (%)
Figure 46. Revenue Breakdown by Type (%)
Figure 47. Revenue Breakdown by Application (%)
Figure 48. Industrial Chain
Table 1. Top Manufacturers and Market Segmentation
Table 2. Product Introduction, Application, Picture
Table 3. Immune Cell Therapy Drugs Revenue, by Type (Million USD) (2018-2028)
Table 4. Immune Cell Therapy Drugs Production, by Type (K Unit) (2018-2028)
Table 5. Immune Cell Therapy Drugs Demand (K Unit) by Application (2018-2028)
Table 6. Immune Cell Therapy Drugs Demand (Million USD) by Application (2018-2028)
Table 7. The Major Downstream Company in China
Table 8. Regional Market Share in Terms of Production & Demand (2022)
Table 9. Regional Market Share in Terms of Revenue (2022&2027)
Table 10. Ranking of Global Top Immune Cell Therapy Drugs Companies by Revenue, Concentration Ratio in 2022
Table 11. Mergers & Acquisitions, Expansion Plans
Table 12. US Immune Cell Therapy Drugs Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2018-2028)
Table 13. Current and Estimated Production Breakdown by Type (2018-2028)
Table 14. Current and Estimated Demand Breakdown by Type (2018-2028)
Table 15. Current and Estimated Demand Breakdown by Application (2018-2028)
Table 16. Current and Estimated Revenue Breakdown by Type
Table 17. Current and Estimated Revenue Breakdown by Application
Table 18. Europe Immune Cell Therapy Drugs Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2018-2028)
Table 19. Current and Estimated Production Breakdown by Type (2018-2028)
Table 20. Current and Estimated Demand Breakdown by Type (2018-2028)
Table 21. Current and Estimated Demand Breakdown by Application (2018-2028)
Table 22. Current and Estimated Revenue Breakdown by Type
Table 23. Current and Estimated Revenue Breakdown by Application
Table 24. China Immune Cell Therapy Drugs Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2018-2028)
Table 25. Table Current and Estimated Production Breakdown by Type
Table 26. Current and Estimated Demand Breakdown by Type
Table 27. Current and Estimated Demand Breakdown by Application
Table 28. Current and Estimated Revenue Breakdown by Application
Table 29. Japan Immune Cell Therapy Drugs Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2018-2028)
Table 30. Current and Estimated Production Breakdown by Type (2018-2028)
Table 31. Current and Estimated Demand Breakdown by Type (2018-2028)
Table 32. Current and Estimated Demand Breakdown by Application (2018-2028)
Table 33. Current and Estimated Revenue Breakdown by Type
Table 34. Current and Estimated Revenue Breakdown by Application
Table 35. India Immune Cell Therapy Drugs Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2018-2028)
Table 36. Current and Estimated Production Breakdown by Type (2018-2028)
Table 37. Current and Estimated Demand Breakdown by Type (2018-2028)
Table 38. Current and Estimated Demand Breakdown by Application (2018-2028)
Table 39. Current and Estimated Revenue Breakdown by Type
Table 40. Current and Estimated Revenue Breakdown by Application
Table 41. Korea Immune Cell Therapy Drugs Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2018-2028)
Table 42. Current and Estimated Production Breakdown by Type (2018-2028)
Table 43. Current and Estimated Demand Breakdown by Type (2018-2028)
Table 44. Current and Estimated Demand Breakdown by Application (2018-2028)
Table 45. Current and Estimated Revenue Breakdown by Type
Table 46. Current and Estimated Revenue Breakdown by Application
Table 47. Southeast Asia Immune Cell Therapy Drugs Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2018-2028)
Table 48. Table Current and Estimated Demand Breakdown by Type (2018-2028)
Table 49. Current and Estimated Demand Breakdown by Application (2018-2028)
Table 50. Current and Estimated Revenue Breakdown by Type
Table 51. Current and Estimated Revenue Breakdown by Application
Table 52. Market Price (USD/Unit) for Each Type of Immune Cell Therapy Drugs in US (2018-2022)
Table 53. Market Price (USD/Unit) for Each Type of Immune Cell Therapy Drugs in Europe (2018-2022)
Table 54. Market Price (USD/Unit) for Each Type of Immune Cell Therapy Drugs in China (2018-2022)
Table 55. Market Price (USD/Unit) for Each Type of Immune Cell Therapy Drugs in Japan (2018-2022)
Table 56. Market Price (USD/Unit) for Each Type of Immune Cell Therapy Drugs in India (2018-2022)
Table 57. Market Price (USD/Unit) for Each Type of Immune Cell Therapy Drugs in Korea (2018-2022)
Table 58. Market Price (USD/Unit) for Each Type of Immune Cell Therapy Drugs in Southeast Asia (2018-2022)
Table 59. Key Downstream Customer in Each Application Field
Table 60. Aquila BioMedical Profiles
Table 61. Aquila BioMedical Immune Cell Therapy Drugs Product Introduction
Table 62. Aquila BioMedical Immune Cell Therapy Drugs Production (Unit), Revenue (Million USD) (2018-2022)
Table 63. Aquila BioMedical Strategic initiatives
Table 64. BPS Bioscience Profiles
Table 65. BPS Bioscience Immune Cell Therapy Drugs Product Introduction
Table 66. BPS Bioscience Immune Cell Therapy Drugs Production (Unit), Revenue (Million USD) (2018-2022)
Table 67. BPS Bioscience Strategic initiatives
Table 68. Celentyx Profiles
Table 69. Celentyx Immune Cell Therapy Drugs Product Introduction
Table 70. Celentyx Immune Cell Therapy Drugs Production (Unit), Revenue (Million USD) (2018-2022)
Table 71. Celentyx Strategic initiatives
Table 72. Crown Bioscience Profiles
Table 73. Crown Bioscience Immune Cell Therapy Drugs Product Introduction
Table 74. Crown Bioscience Immune Cell Therapy Drugs Production (Unit), Revenue (Million USD) (2018-2022)
Table 75. Crown Bioscience Strategic initiatives
Table 76. DiscoverX Corporation Profiles
Table 77. DiscoverX Corporation Immune Cell Therapy Drugs Product Introduction
Table 78. DiscoverX Corporation Immune Cell Therapy Drugs Production (Unit), Revenue (Million USD) (2018-2022)
Table 79. DiscoverX Corporation Strategic initiatives
Table 80. Explicyte Profiles
Table 81. Explicyte Immune Cell Therapy Drugs Product Introduction
Table 82. Explicyte Immune Cell Therapy Drugs Production (Unit), Revenue (Million USD) (2018-2022)
Table 83. Explicyte Strategic initiatives
Table 84. Genscript Biotech Corporation Profiles
Table 85. Genscript Biotech Corporation Immune Cell Therapy Drugs Product Introduction
Table 86. Genscript Biotech Corporation Immune Cell Therapy Drugs Production (Unit), Revenue (Million USD) (2018-2022)
Table 87. Genscript Biotech Corporation Strategic initiatives
Table 88. HD Biosciences Profiles
Table 89. HD Biosciences Immune Cell Therapy Drugs Product Introduction
Table 90. HD Biosciences Immune Cell Therapy Drugs Production (Unit), Revenue (Million USD) (2018-2022)
Table 91. HD Biosciences Strategic initiatives
Table 92. Horizon Discovery Group Profiles
Table 93. Horizon Discovery Group Immune Cell Therapy Drugs Product Introduction
Table 94. Horizon Discovery Group Immune Cell Therapy Drugs Production (Unit), Revenue (Million USD) (2018-2022)
Table 95. Horizon Discovery Group Strategic initiatives
Table 97. ImmunXperts Profiles
Table 98. ImmunXperts Immune Cell Therapy Drugs Product Introduction
Table 99. ImmunXperts Immune Cell Therapy Drugs Production (Unit), Revenue (Million USD) (2018-2022)
Table 100. ImmunXperts Strategic initiatives
Table 101. Molecular Imaging Profiles
Table 102. Molecular Imaging Immune Cell Therapy Drugs Product Introduction
Table 103. Molecular Imaging Immune Cell Therapy Drugs Production (Unit), Revenue (Million USD) (2018-2022)
Table 104. Molecular Imaging Strategic initiatives
Table 105. Promega Corporation,Personalis Profiles
Table 106. Promega Corporation,Personalis Immune Cell Therapy Drugs Product Introduction
Table 107. Promega Corporation,Personalis Immune Cell Therapy Drugs Production (Unit), Revenue (Million USD) (2018-2022)
Table 108. Promega Corporation,Personalis Strategic initiatives
Table 109. STC Biologics Profiles
Table 110. STC Biologics Immune Cell Therapy Drugs Product Introduction
Table 111. STC Biologics Immune Cell Therapy Drugs Production (Unit), Revenue (Million USD) (2018-2022)
Table 112. STC Biologics Strategic initiatives